Geneos Wealth Management’s Federated Hermes FHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$1.69K 2160
2023
Q4
$1.69K Hold
50
﹤0.01% 1943
2023
Q3
$1.69K Buy
+50
New +$1.72K ﹤0.01% 1959
2021
Q2
Sell
-400
Closed -$11K 2938
2021
Q1
$11K Buy
+400
New +$11.8K ﹤0.01% 2335
2018
Q2
Sell
-578
Closed -$19K 2280
2018
Q1
$19K Buy
578
+200
+53% +$6.79K ﹤0.01% 1409
2017
Q4
$13K Hold
378
﹤0.01% 1537
2017
Q3
$11K Hold
378
﹤0.01% 1542
2017
Q2
$10K Buy
378
+190
+101% +$5.07K ﹤0.01% 1527
2017
Q1
$4K Buy
+188
New +$5.03K ﹤0.01% 1733
2016
Q3
Sell
-300
Closed -$8K 1973
2016
Q2
$8K Hold
300
﹤0.01% 1391
2016
Q1
$8K Buy
+300
New +$7.89K ﹤0.01% 1375

Other funds holding FHI

Geneos Wealth Management's FHI Position: Q1 2024 in Review

Geneos Wealth Management sold out of Federated Hermes (FHI) in Q1 2024, closing a stake of 50 shares — an estimated $1.69K sold.

Geneos Wealth Management first reported a position in FHI in Q1 2016 and held it in 10 quarters. The position peaked at $19K in Q1 2018. 316 funds tracked by Wall St. Rank hold FHI as of Q1 2024.

  • Geneos Wealth Management reported no remaining Federated Hermes position as of Q1 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 50 Federated Hermes shares in Q1 2024, an estimated $1.69K.
  • Geneos Wealth Management first reported a position in Federated Hermes in Q1 2016 and held it in 10 quarters.
  • Geneos Wealth Management's Federated Hermes position peaked at $19K in Q1 2018.
  • 316 funds tracked by Wall St. Rank held Federated Hermes as of Q1 2024.

Based on Geneos Wealth Management's 13F filing for Q1 2024, filed 3 May 2024.